Stephen C. Glover - 28 Feb 2025 Form 4 Insider Report for PDS Biotechnology Corp (PDSB)

Reporting relationship: Director
Issuer ticker: PDSB
Reported as of: 28 Feb 2025
Net transaction value: +$25,001
SEC form: 4
Accepted by SEC: 03 Mar 2025, 16:45:20 UTC
Prior SEC filing: 25 Jun 2024
Next SEC filing: 11 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ Spencer Brown, as Attorney-in-Fact

Key filing fact

Stephen C. Glover filed Form 4 for PDS Biotechnology Corp (PDSB) on 03 Mar 2025.

Key facts

This page summarizes Stephen C. Glover's Form 4 filing for PDS Biotechnology Corp (PDSB).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 03 Mar 2025, 16:45.

Change

Previous filing in this sequence was filed on 25 Jun 2024.
Current net transaction value: +$25,001.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PDSB transaction

Common Stock

Purchase

Transaction value: $25,001
Shares: +15,061
Change %: +24%
Price: $1.66
Shares after: 78,851
Date: 28 Feb 2025
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PDSB transaction Derivative

Common Warrant

Purchase

Transaction value
Shares: +15,061
Change %
Price
Shares after: 15,061
Date: 28 Feb 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 15,061
Exercise price: $1.53
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The purchase price for the Common Warrant is included in the purchase price for the shares of Common Stock reflected in Table I above.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .